The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Open accessAbstract
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells. Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [5]
In the citing paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
From High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (2020) · cites this paper as [7]
In the citing paper
“The cell surface receptor for the CoV-1 and CoV-2 surface spike protein has been identified by affinity-MS to be angiotensin-converting enzyme 2 (ACE2)147”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [147]
In the citing paper
“As an alternative approach, cellular interaction partners for a single viral protein of interest have also been investigated by in vitro incubation of the viral protein bait with lysates from uninfected permissive cells.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“while promoted upon ACE2 overexpression in HEK293T cells that are otherwise non-permissive to SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“which was further functionally characterized as a functional receptor for SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“MS analysis revealed the cellular metallopeptidase angiotensin-converting enzyme 2 (ACE2) as an S1 interaction partner”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“Viral replication was inhibited upon incubation with antibodies against ACE2”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“This interaction requires cleavage of the S protein, likely by the cell surface protease TMPRSS2, although other proteases (such as Cathepsin B and L, CTSB/CTSL) may also be involved (4-6, 22-25).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“CoV-2 — like SARS-CoV — infects cells through interactions between its spike (S) protein and the ACE2 protein on target cells.”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“ACE2 is the functional entry receptor for both severe acute respiratory syndrome (SARS) coronaviruses, SARS-CoV (36) and SARS-CoV-2 (37).”
From TCRD and pharos 2021: mining the human proteome for disease biology (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N. J., Rollins, B. J., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. J., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,286
Self-citationA Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015
Cited by
Sorted by citations
Items 901–1,000 of 1,026
Tusell, S. M., Schittone, S. A., & Holmes, K. V. (2006) · Journal of Virology · doi:10.1128/jvi.01510-06 · Cited by 114
Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1–7/Mas axis
Uhal, B. D., Li, X., Xue, A., Gao, X., & Abdul‐Hafez, A. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00222.2010 · Cited by 114
The looming storm: Blood and cytokines in COVID-19
Kaur, S., Bansal, R., Kollimuttathuillam, S., Gowda, A. M., Singh, B., Mehta, D., & Maroules, M. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100743 · Cited by 113
Lum, K. K., & Cristea, I. M. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1147353 · Cited by 113
Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
Rey-Parra, G., Vadivel, A., Coltan, L., Hall, A., Eaton, F., Schuster, M., Loibner, H., Penninger, J. M., Kassiri, Z., Oudit, G. Y., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0859-2 · Cited by 113
Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
Yuan, K., Yi, L., Chen, J., Qu, X., Qing, T., Rao, X., Jiang, P., Hu, J., Xiong, Z., Nie, Y., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.046 · Cited by 113
Takasuka, N. (2004) · International Immunology · doi:10.1093/intimm/dxh143 · Cited by 113
COVID-19 and fertility: a virtual reality
Anifandis, G., Messini, C. I., Daponte, A. I., & Messinis, I. E. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.05.001 · Cited by 113
Carino, A., Moraca, F., Fiorillo, B., Marchianò, S., Sepe, V., Biagioli, M., Finamore, C., Bozza, S., Francisci, D., Distrutti, E., et al. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.572885 · Cited by 113
Schloer, S., Brunotte, L., Mecate‐Zambrano, A., Zheng, S., Tang, J. P., Ludwig, S., & Rescher, U. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15418 · Cited by 113
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Mengist, H. M., Kombe, A. J. K., Mekonnen, D. S., Abebaw, A., Getachew, M., & Jin, T. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101533 · Cited by 115
TMPRSS2 is a functional receptor for human coronavirus HKU1
Saunders, N., Fernandez, I., Planchais, C., Michel, V., Rajah, M. M., Baquero, E., Postal, J., Porrot, F., Guivel‐Benhassine, F., Blanc, C., et al. (2023) · Nature · doi:10.1038/s41586-023-06761-7 · Cited by 113
Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A
Luo, C., Luo, H., Zheng, S., Gui, C., Yue, L., Yu, C., Sun, T., He, P., Chen, J., Shen, J., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.003 · Cited by 112
In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
Ling, R., Dai, Y., Huang, B., Huang, W., Yu, J., Lu, X., & Jiang, Y.-Z. (2020) · Peptides · doi:10.1016/j.peptides.2020.170328 · Cited by 112
Bottari, B., Castellone, V., & Neviani, E. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1807475 · Cited by 112
Beumer, J., Geurts, M. H., Lamers, M. M., Puschhof, J., Zhang, J., van der Vaart, J., Mykytyn, A. Z., Breugem, T. I., Riesebosch, S., Schipper, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25729-7 · Cited by 113
Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
Wong, G., Bi, Y., Wang, Q.-H., Chen, X.-W., Zhang, Z., & Yao, Y. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.031 · Cited by 113
Berry, J. D., Hay, K. A., Rini, J. M., Yu, M., Wang, L., Plummer, F. A., Corbett, C. R., & Andonov, A. P. (2010) · mAbs · doi:10.4161/mabs.2.1.10788 · Cited by 111
Greenough, T. C., Carville, A., Coderre, J. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., & Mansfield, K. G. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62989-6 · Cited by 111
Self-citationDevelopment and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
Berry, J. D., Jones, S. J. M., DREBOT, M. A., Andonov, A. P., Sabara, M. I. J., Yuan, X. Y., Weingartl, H. M., Fernando, L., Marszal, P., Gren, J., et al. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.04.009 · Cited by 111
Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India
Srivastava, A., Bandopadhyay, A., Das, D., Pandey, R. K., Singh, V., Khanam, N., Srivastava, N., Singh, P. P., Dubey, P. K., Pathak, A., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.564741 · Cited by 111
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Abulsoud, A. I., El‐Husseiny, H. M., El-Husseiny, A. A., El‐Mahdy, H. A., Ismail, A., Elkhawaga, S. Y., Khidr, E. G., Fathi, D., Mady, E. A., Najda, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113977 · Cited by 112
Lau, S. K. P., Li, K. S. M., Tsang, A. K. L., Shek, C. T., Wang, M., Choi, G. K.-Y., Guo, R., Wong, B. H. L., Poon, R. W., Lam, C. S. F., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01305-12 · Cited by 110
Ritchie, G. E., Harvey, D. J., Feldmann, F., Ströeher, U., Feldmann, H., Royle, L., Dwek, R. A., & Rudd, P. M. (2010) · Virology · doi:10.1016/j.virol.2009.12.020 · Cited by 110
Receptor-binding loops in alphacoronavirus adaptation and evolution
Wong, A. H. M., Tomlinson, A. C. A., Zhou, D., Satkunarajah, M., Chen, K., Sharon, C., Desforges, M., Talbot, P. J., & Rini, J. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01706-x · Cited by 110
Diabetes and metabolic syndrome as risk factors for COVID-19
Marhl, M., Grubelnik, V., Magdič, M., & Markovič, R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.013 · Cited by 110
Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin
Gallelli, L., Zhang, L., Wang, T., & Fu, F. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1644 · Cited by 110
Campione, E., Cosio, T., Rosa, L., Lanna, C., Girolamo, S. D., Gaziano, R., Valenti, P., & Bianchi, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144903 · Cited by 110
Asghari, A., Wang, C., Yoo, K. M., Rostamian, A., Xu, X., Shin, J.-D., Dalir, H., & Chen, R. T. (2021) · Applied Physics Reviews · doi:10.1063/5.0022211 · Cited by 110
Hörnich, B. F., Großkopf, A. K., Schlagowski, S., Tenbusch, M., Kleine‐Weber, H., Neipel, F., Stahl‐Hennig, C., & Hahn, A. S. (2021) · Journal of Virology · doi:10.1128/jvi.00002-21 · Cited by 110
Cennamo, N., D’Agostino, G., Perri, C., Arcadio, F., Chiaretti, G., Parisio, E. M., Camarlinghi, G., Vettori, C., Marzo, F. D., Cennamo, R., et al. (2021) · Sensors · doi:10.3390/s21051681 · Cited by 110
Current Strategies of Antiviral Drug Discovery for COVID-19
Mei, M., & Tan, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671263 · Cited by 111
Animal models for COVID-19: advances, gaps and perspectives
Fan, C., Wu, Y., Xiong, R., Yang, Y., Ling, C., Liu, S., Liu, S., & Wang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01087-8 · Cited by 110
Bisht, H., Roberts, A., Vogel, L., Subbarao, K., & Moss, B. (2005) · Virology · doi:10.1016/j.virol.2005.01.042 · Cited by 109
Guo, H., Hu, B., Yang, X., Zeng, L., Li, B., Ouyang, S., & Shi, Z. (2020) · Journal of Virology · doi:10.1128/jvi.00902-20 · Cited by 109
Severe COVID-19: A multifaceted viral vasculopathy syndrome
MAGRO, C. M. J., Mulvey, J. J., Kubiak, J. M., Mikhail, S., Suster, D. I., CROWSON, A. N., Laurence, J. C., & Nuovo, G. J. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151645 · Cited by 109
Zhu, J., Xiao, G., Xu, Y., Yuan, F., Zheng, C., Liu, Y., Yan, H., Cole, D. K., Bell, J. I., Rao, Z., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.141 · Cited by 109
Mizutani, T., Fukushi, S., Saijo, M., Kurane, I., & Morikawa, S. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.004 · Cited by 108
Meher, G., Bhattacharjya, S., & Chakraborty, H. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b08455 · Cited by 108
Lakhani, H. V., Pillai, S. S., Zehra, M., Sharma, I., & Sodhi, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17124279 · Cited by 108
Deshpande, R. R., Tiwari, A. P., Nyayanit, N., & Modak, M. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173430 · Cited by 108
COVID-19 and diabetes mellitus: how one pandemic worsens the other
Azar, W. S., Njeim, R., Fares, A. H., Azar, N. S., Azar, S. T., Sayed, M. J. E., & Eid, A. A. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09573-6 · Cited by 109
Smoking and COVID-19: Adding Fuel to the Flame
Kashyap, V. K., Dhasmana, A., Massey, A. E., Kotnala, S., Zafar, N., Jaggi, M., Yallapu, M. M., & Chauhan, S. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186581 · Cited by 108
Lam, S. D., Bordin, N., Waman, V., Scholes, H. M., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N. L., Pang, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71936-5 · Cited by 109
Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
Udupa, A., Leverenz, D. L., Balevic, S. J., Sadun, R. E., Tarrant, T. K., & Rogers, J. L. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00983-9 · Cited by 108
Piplani, S., Singh, P. K., Winkler, D. A., & Petrovsky, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-92388-5 · Cited by 109
Sauvé, F., Nampoothiri, S. S., Clarke, S. A., Fernandois, D., Coêlho, C. F. F., Dewisme, J., Mills, E., Ternier, G., Cotellessa, L., Iglesias, C., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104784 · Cited by 109
Cellular Immunity and Lung Injury in Respiratory Virus Infection
Bruder, D., Srikiatkhachorn, A., & Enelow, R. I. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.147 · Cited by 108
Chen, J., Chang, Y., Yao, C., Chiueh, T., Huang, S., Chien, K.-Y., Chen, A., Chang, F., Wong, C., & Chen, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407992101 · Cited by 108
Nie, Y., Wang, P., Shi, X., Wang, G., Chen, J., Zheng, A., Wang, W., Wang, Z., Qu, X., Luo, M., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.060 · Cited by 107
Treml, B., Neu, N., Kleinsasser, A. T., Gritsch, C., Finsterwalder, T., Geiger, R., Schuster, M., Janzek, E., Loibner, H., Penninger, J. M., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c03009 · Cited by 107
Kong, S. L., Chui, P., Lim, B., & Salto‐Tellez, M. (2009) · Virus Research · doi:10.1016/j.virusres.2009.07.014 · Cited by 107
LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2
Zhao, X., Zheng, S., Chen, D., Zheng, M., Li, X., Li, G., Lin, H., Chang, J., Zeng, H., & Guo, J. (2020) · Journal of Virology · doi:10.1128/jvi.00562-20 · Cited by 107
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
Xie, Y., Karki, C. B., Du, D., Li, H., Wang, J., Sobitan, A., Teng, S., Tang, Q., & Li, L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.591873 · Cited by 107
Wurtz, N., Penant, G., Jardot, P., Duclos, N., & Scola, B. L. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04106-0 · Cited by 107
SARS‐CoV‐2 infection and multi-organ system damage: A review
Rabaan, A. A., Smajlović, S., Tombuloğlu, H., Ćordić, S., Hajdarević, A., Kudić, N., Mutai, A. A., Turkistani, S. A., Al-Ahmed, S. H., Al-Zaki, N. A., et al. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2022.7762 · Cited by 107
Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry
Li, W., Luo, R., He, Q., van Kuppeveld, F. J. M., Rottier, P. J. M., & Bosch, B. (2017) · Virus Research · doi:10.1016/j.virusres.2017.03.018 · Cited by 107
Self-citationAntihypertensive drugs and risk of COVID-19?
Tignanelli, C. J., Ingraham, N. E., Sparks, M. A., Reilkoff, R. A., Bezdicek, T. L., Benson, B., Schacker, T. W., Chipman, J. G., & Puskarich, M. A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30153-3 · Cited by 108
Yan, T., Xiao, R., & Lin, G. (2020) · The FASEB Journal · doi:10.1096/fj.202000782 · Cited by 106
Khelfaoui, H., Harkati, D., & Saleh, B. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1803967 · Cited by 106
Khalifa, S. A. M., Yosri, N., El-Mallah, M. F., Ghonaim, R., Guo, Z., Musharraf, S. G., Du, M., Khatib, A., Xiao, J., Saeed, A., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153311 · Cited by 106
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Saponaro, F., Rutigliano, G., Sestito, S., Bandini, L., Storti, B., Bizzarri, R., & Zucchi, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.588618 · Cited by 106
SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles
Plescia, C. B., David, E. A., Patra, D., Sengupta, R., Amiar, S., Su, Y., & Stahelin, R. V. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016148 · Cited by 106
SARS coronavirus 2: from genome to infectome
Rastogi, M., Pandey, N., Shukla, A., & Singh, S. K. (2020) · Respiratory Research · doi:10.1186/s12931-020-01581-z · Cited by 107
Singh, H., Choudhari, R. H., Nema, V., & Khan, A. A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104621 · Cited by 106
The therapeutic potential of apelin in kidney disease
Chapman, F. A., Nyimanu, D., Maguire, J. J., Davenport, A. P., Newby, D. E., & Dhaun, N. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00461-z · Cited by 106
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
Xie, F., Su, P., Pan, T. S., Zhou, X., Li, H., Huang, H., Wang, A., Wang, F., Huang, J., Yan, H., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103471 · Cited by 105
Nam, E., & Lee, C. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.12.024 · Cited by 104
Hassamal, S., Miotto, K. A., Wang, T. S., & Saxon, A. J. (2016) · American Journal on Addictions · doi:10.1111/ajad.12424 · Cited by 104
Stoian, A. P., Banerjee, Y., Rizvi, A. A., & Rizzo, M. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0037 · Cited by 104
Covid-19 pandemic and food: Present knowledge, risks, consumers fears and safety
Duda‐Chodak, A., Łukasiewicz, M., Zięć, G., Florkiewicz, A., & Filipiak‐Florkiewicz, A. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.08.020 · Cited by 105
Tsai, K., Huang, Y.-C., Liaw, C., Tsai, C.-I., Chiou, C., Lin, C.-J., Wei, W., Lin, J., Tseng, Y.-H., Yeh, K., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111037 · Cited by 104
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Chen, J., Zhang, W., Li, Y., Liu, C., Dong, T., Chen, H., Wu, C., Su, J., Li, B., Zhang, W., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.042 · Cited by 106
Lip, K.-M., Shen, S., Yang, X., Keng, C. T., Zhang, A., Oh, H. J., Li, Z., Hwang, L., Chou, C.-F., Fielding, B. C., et al. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.941-950.2006 · Cited by 103
Molecular Biology of the SARS-Coronavirus
Lal, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-642-03683-5 · Cited by 103
Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_4 · Cited by 104
Chen, L., & Hao, G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa093 · Cited by 104
Immune Response and COVID-19: A mirror image of Sepsis
López‐Collazo, E., Ortiz, J. A., Martín‐Quirós, A., & Aguirre, L. A. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48400 · Cited by 103
Artese, A., Svicher, V., Costa, G., Salpini, R., Maio, V. C. D., Alkhatib, M., Ambrosio, F. A., Santoro, M. M., Assaraf, Y. G., Alcaro, S., et al. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100721 · Cited by 103
Pregnancy and COVID-19: management and challenges
Wenling, Y., Qiu, J., Xiao, Z., & Ouyang, S. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062062 · Cited by 103
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
Mudgal, R. K., Nehul, S., & Tomar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1805992 · Cited by 103
The cytokine storm and thyroid hormone changes in COVID-19
Croce, L., Gangemi, D., Ancona, G., Liboà, F., Bendotti, G., Minelli, L., & Chiovato, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01506-7 · Cited by 103
COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury
Nicosia, R. F., Ligresti, G., Caporarello, N., Akilesh, S., & Ribatti, D. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.05.007 · Cited by 105
Rossi, G. A., Sacco, O., Mancino, E., Cristiani, L., & Midulla, F. (2020) · Infection · doi:10.1007/s15010-020-01486-5 · Cited by 102
Steinman, J. B., Lum, F., Ho, P. P.-K., Kaminski, N., & Steinman, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012358117 · Cited by 102
Tang, B. S. F., Chan, K., Cheng, V. C., Woo, P. C. Y., Lau, S. K. P., Lam, C. C. K., Chan, T., Wu, A. K. L., Hung, I. F., Leung, S.-Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6180-6193.2005 · Cited by 102
Keng, C. T., Zhang, A., Shen, S., Lip, K.-M., Fielding, B. C., Tan, T. H. P., Chou, C.-F., Loh, C. B., Wang, S., Fu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3289-3296.2005 · Cited by 101
Cole‐Jeffrey, C. T., Liu, M., Katovich, M. J., Raizada, M. K., & Shenoy, V. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000307 · Cited by 101
Szczepański, A., Owczarek, K., Bzowska, M., Gula, K., Drebot, I., Ochman, M., Maksym, B., Rajfur, Z., Mitchell, J. A., & Pyrć, K. (2019) · Viruses · doi:10.3390/v11040328 · Cited by 101
Tse, L. V., Meganck, R. M., Graham, R. L., & Baric, R. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00658 · Cited by 101
Aiello, F., Afflitto, G. G., Mancino, R., Li, J.-P. O., Cesareo, M., Giannini, C., & Nucci, C. (2020) · Eye · doi:10.1038/s41433-020-0926-9 · Cited by 101
Hepatic consequences of COVID-19 infection. Lapping or biting?
Portincasa, P., Krawczyk, M. J., Machill, A., Lammert, F., & Ciaula, A. D. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.035 · Cited by 101
Vallamkondu, J., John, A. A., Wani, W. Y., Ramadevi, S., Jella, K. K., Reddy, P. H., & Kandimalla, R. J. L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165889 · Cited by 101
Caldas, L. A., Carneiro, F. A., Higa, L. M., Monteiro, F. L. L., da Silva, G. P., da Costa, L. J., Durigon, E. L., Tanuri, A., & de Souza, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-73162-5 · Cited by 101
Variants in ACE2; potential influences on virus infection and COVID-19 severity
Bakhshandeh, B., Sorboni, S. G., Javanmard, A., Mottaghi, S. S., Mehrabi, M., Sorouri, F., Abbasi, A., & Jahanafrooz, Z. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104773 · Cited by 101
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009772 · Cited by 101
Zhang, Z., Cui, F., Cao, C., Wang, Q., & Zou, Q. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105092 · Cited by 101
Carossino, M., Kenney, D., O’Connell, A. K., Montanaro, P., Tseng, A. E., Gertje, H. P., Grosz, K. A., Ericsson, M., Huber, B. R., Kurnick, S. A., et al. (2022) · Viruses · doi:10.3390/v14030535 · Cited by 101
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Ng, T. I., Correia, I., Seagal, J., DeGoey, D. A., Schrimpf, M. R., Hardee, D. J., Noey, E. L., & Kati, W. M. (2022) · Viruses · doi:10.3390/v14050961 · Cited by 101
Zhou, M., Xu, D., Li, X., Li, H., Shan, M., Tang, J., Wang, M., Wang, F., Zhu, X., Tao, H., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2138 · Cited by 100
Metadata
- Authors
- Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Tufts University (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Choe, Hyeryun
- Farzan, Michael
- ORCID
- Venue
- Nature
- Published
- 2003-11-27
- Volume
- 426
- Issue
- 6965
- Pages
- 450-454
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7095016
- OpenAlex
- W1966238900
- Cited by
- 5,923
- References
- 32
- Citations by year
- 2026: 74 · 2025: 145 · 2024: 298 · 2023: 448 · 2022: 732 · 2021: 1288 · 2020: 1794 · 2019: 32 · 2018: 30 · 2017: 44 · 2016: 50 · 2015: 49 · 2014: 62 · 2013: 43 · 2012: 50
- FWCI
- 79.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- National Aeronautics and Space Administration
- Hawaii Community Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- angiotensin-converting enzyme 2, SARS coronavirus, viral receptor, receptor binding, syncytium formation, viral replication, ACE1, Vero E6 cells, HEK293T cells, antibody inhibition
- MeSH terms
- Angiotensin-Converting Enzyme 2, Animals, Antibodies, Carboxypeptidases, Cell Line, Chlorocebus aethiops, Humans, Peptidyl-Dipeptidase A, Membrane Glycoproteins, Molecular Weight, Protein Binding, Receptors, Virus, Solubility, Transfection, Vero Cells, Viral Envelope Proteins, Virus Replication, Giant Cells, Protein Structure, Tertiary, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
